{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-040784","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2025-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.087379+00:00","generated_at":"2026-05-24T13:40:02.089301+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Jaguar Health announces 1-for-25 reverse stock split effective March 24 to meet Nasdaq compliance","bullets":["Reverse split at 1-for-25 ratio, effective March 24, 2025 at 12:01 am ET.","Purpose: support compliance with Nasdaq listing standards and attract institutional investors.","No fractional shares; stockholders otherwise entitled to fractional shares receive cash in lieu.","New CUSIP number for post-split common stock is 47010C888.","Stockholder approval obtained at March 13, 2025 special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-040784","json":"https://secwatch.observer/filing/0000950170-25-040784.json","markdown":"https://secwatch.observer/filing/0000950170-25-040784.md","text":"https://secwatch.observer/filing/0000950170-25-040784.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000095017025040784/0000950170-25-040784-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000095017025040784/jagx-20250318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T13:40:02.089301+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}